745
Views
79
CrossRef citations to date
0
Altmetric
Original

Environment and systemic lupus erythematosus: An overview

, , &
Pages 465-472 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Alya Halkom, Haijing Wu & Qianjin Lu. (2020) Contribution of mouse models in our understanding of lupus. International Reviews of Immunology 39:4, pages 174-187.
Read now
Stephen L. Rego, Scott Harvey, Sean R. Simpson, Wayne O. Hemphill, Zachariah A. McIver, Jason M. Grayson & Fred W. Perrino. (2018) TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis. Autoimmunity 51:7, pages 333-344.
Read now
NS Rasmussen, AH Draborg, CT Nielsen, S Jacobsen & G Houen. (2015) Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scandinavian Journal of Rheumatology 44:2, pages 143-149.
Read now
B Zöller, X Li, J Sundquist & K Sundquist. (2013) Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden. Scandinavian Journal of Rheumatology 42:6, pages 487-497.
Read now
Hans Helmut Niller, Hans Wolf & Janos Minarovits. (2008) Regulation and dysregulation of Epstein–Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 41:4, pages 298-328.
Read now
Piercarlo Sarzi-Puttini & Andrea Doria. (2008) Organ specific-autoantibodies: Their role as markers and predictors of disease. Autoimmunity 41:1, pages 1-10.
Read now
Dr Nicola Gullick & Dr David D’Cruz. (2007) New therapies for the treatment of systemic lupus erythematosus. Expert Opinion on Therapeutic Patents 17:3, pages 299-313.
Read now
Andreas Jönsen, Anders A. Bengtsson, Ola Nived, Lennart Truedsson & Gunnar Sturfelt. (2007) Gene–environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 40:8, pages 613-617.
Read now

Articles from other publishers (71)

Margherita Zen, Laura Salmaso, Claudio Barbiellini Amidei, Ugo Fedeli, Stefania Bellio, Luca Iaccarino, Alessandro Giollo, Andrea Doria & Mario Saia. (2023) Systemic lupus erythematosus incidence and prevalence in a large population-based study in northeastern Italy. Rheumatology 62:8, pages 2773-2779.
Crossref
Mariangela Salvato & Andrea Doria. (2023) Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?. Autoimmunity Reviews, pages 103419.
Crossref
Ioannis Parodis, Roberto Depascale, Andrea Doria & Hans-Joachim Anders. (2023) When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?. Autoimmunity Reviews, pages 103418.
Crossref
Liliana Saraiva, Rita N Cunha, Diogo Jesus, Mariele Gatto, Margherita Zen, Luca Iaccarino, José A P da Silva, Andrea Doria & Luís Sousa Inês. (2023) The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study. Rheumatology.
Crossref
Margherita Zen, Laura Salmaso, Claudio Barbiellini Amidei, Ugo Fedeli, Stefania Bellio, Luca Iaccarino, Andrea Doria & Mario Saia. (2023) Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based study. European Journal of Internal Medicine 112, pages 45-51.
Crossref
Margherita Zen, Mariele Gatto, Roberto Depascale, Francesca Regola, Micaela Fredi, Laura Andreoli, Franco Franceschini, Maria Letizia Urban, Giacomo Emmi, Fulvia Ceccarelli, Fabrizio Conti, Alessandra Bortoluzzi, Marcello Govoni, Chiara Tani, Marta Mosca, Tania Ubiali, Maria Gerosa, Enrica P. Bozzolo, Valentina Canti, Paolo Cardinaletti, Armando Gabrielli, Giacomo Tanti, Elisa Gremese, Ginevra De Marchi, Salvatore De Vita, Serena Fasano, Francesco Ciccia, Giulia Pazzola, Carlo Salvarani, Simone Negrini, Andrea Di Matteo, Rossella De Angelis, Giovanni Orsolini, Maurizio Rossini, Paola Faggioli, Antonella Laria, Matteo Piga, Alberto Cauli, Salvatore Scarpato, Francesca Wanda Rossi, Amato De Paulis, Enrico Brunetta, Angela Ceribelli, Carlo Selmi, Marcella Prete, Vito Racanelli, Angelo Vacca, Elena Bartoloni, Roberto Gerli, Elisabetta Zanatta, Maddalena Larosa, Francesca Saccon, Andrea Doria & Luca Iaccarino. (2023) Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS). Journal of Personalized Medicine 13:4, pages 691.
Crossref
Yagmur Kan, YiTing Paung, Yunyoung Kim, Markus A. Seeliger & W. Todd Miller. (2023) Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. Biochemistry 62:6, pages 1124-1137.
Crossref
Maysaa El Sayed Zaki, Mostafa Abdelsalam, Sherine A. R. A. K Bassiouni & Asmaa Osman. (2021) Gene Polymorphism of XRCC1 in Systemic Lupus Erythematous. The Open Rheumatology Journal 15:1, pages 24-30.
Crossref
Mohamed A. Mortada, Haidy E. Zidan, Noha A. Abdelsalam & Mirvat A. Eltoukhy. (2020) Gene XRCC1Arg399Gln polymorphism and its genotype variations: clinical associations in Egyptian systemic lupus erythematosus patients. Egyptian Rheumatology and Rehabilitation 47:1.
Crossref
Federica Romano, Filippo Citterio, Valeria Manavella, Laura Bianco & Mario Aimetti. (2020) Desquamative Diseases and Periodontal Health/Treatment. Current Oral Health Reports 7:2, pages 129-138.
Crossref
Acharya Balkrishna, Pallavi Thakur, Shivam Singh, Swami Narsingh Chandra Dev & Anurag Varshney. (2020) Mechanistic Paradigms of Natural Plant Metabolites as Remedial Candidates for Systemic Lupus Erythromatosus. Cells 9:4, pages 1049.
Crossref
Chang-Youh Tsai, Song-Chou Hsieh, Cheng-Shiun Lu, Tsai-Hung Wu, Hsien-Tzung Liao, Cheng-Han Wu, Ko-Jen Li, Yu-Min Kuo, Hui-Ting Lee, Chieh-Yu Shen & Chia-Li Yu. (2019) Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. International Journal of Molecular Sciences 20:20, pages 5183.
Crossref
Chang-Youh Tsai, Chieh-Yu Shen, Hsien-Tzung Liao, Ko-Jen Li, Hui-Ting Lee, Cheng-Shiun Lu, Cheng-Han Wu, Yu-Min Kuo, Song-Chou Hsieh & Chia-Li Yu. (2019) Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences 20:16, pages 3878.
Crossref
Katerina Damevska, Suzana Nikolovska, Jana Kazandjieva, Bisera Kotevska Trifunova & Georgeta Bocheva. 2019. Advances in Integrative Dermatology. Advances in Integrative Dermatology 379 392 .
S. Sam Lim & Cristina Drenkard. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 23 43 .
Zhengwei Zhu, Chao Yang, Leilei Wen, Lu Liu, Xianbo Zuo, Fusheng Zhou, Jinping Gao, Xiaodong Zheng, Yinjuan Shi, Caihong Zhu, Bo Liang, Xianyong Yin, Wenjun Wang, Hui Cheng, Songke Shen, Xianfa Tang, Huayang Tang, Liangdan Sun, Anping Zhang, Sen Yang, Yong Cui, Xuejun Zhang & Yujun Sheng. (2018) RETRACTED: Bach2 regulates aberrant activation of B cell in systemic lupus erythematosus and can be negatively regulated by BCR-ABL/PI3K. Experimental Cell Research 365:1, pages 138-144.
Crossref
Anette Holck Draborg, Niclas Stefan Rasmussen, Janni Lisander Larsen, Charlotte Sværke Jørgensen, Noreen Sandhu, Kristin Skogstrand, Søren Jacobsen & Gunnar Houen. (2018) Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status. PLOS ONE 13:3, pages e0193244.
Crossref
Farinaz Jafari Ghods, Aysegul Topal Sarikaya, Nazli Arda & Vedat Hamuryudan. (2017) MiRNA and mRNA Profiling in Systemic Lupus Reveals a Novel Set of Cytokine - Related miRNAs and their Target Genes in Cases With and Without Renal Involvement. Kidney and Blood Pressure Research 42:6, pages 1322-1337.
Crossref
Melissa E. Munroe & Judith A. James. (2015) Genetics of Lupus Nephritis: Clinical Implications. Seminars in Nephrology 35:5, pages 396-409.
Crossref
Antonella Afeltra, Antonietta Gigante, Domenico Paolo Emanuele Margiotta, Chiara Taffon, Rosario Cianci, Biagio Barbano, Marta Liberatori, Antonio Amoroso & Filippo Rossi Fanelli. (2015) The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study. Internal and Emergency Medicine 10:6, pages 677-683.
Crossref
Guanjun Dong, Ming You, Liang Ding, Hongye Fan, Fei Liu, Deshan Ren & Yayi Hou. (2015) STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells. Molecules and Cells 38:5, pages 441-451.
Crossref
Panneer Devaraju, Reena Gulati, Paul T. Antony, C.B. Mithun & Vir S. Negi. (2015) Susceptibility to SLE in South Indian Tamils may be influenced by genetic selection pressure on TLR2 and TLR9 genes. Molecular Immunology 64:1, pages 123-126.
Crossref
L Schiffer, K Worthmann, H Haller & M Schiffer. (2015) CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis – from bench to bedside?. Clinical and Experimental Immunology 179:1, pages 85-89.
Crossref
Norbert O. Temajo & Neville Howard. (2014) The mosaic of environment involvement in autoimmunity: The abrogation of viral latency by stress, a non-infectious environmental agent, is an intrinsic prerequisite prelude before viruses can rank as infectious environmental agents that trigger autoimmune diseases. Autoimmunity Reviews 13:6, pages 635-640.
Crossref
P Nelson, P Rylance, D Roden, M Trela & N Tugnet. (2014) Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 23:6, pages 596-605.
Crossref
Edith M. Williams, Kasim Ortiz & Teri Browne. (2014) Social Determinants of Health, the Chronic Care Model, and Systemic Lupus Erythematosus. International Journal of Chronic Diseases 2014, pages 1-7.
Crossref
Chau-Ching Liu, Amy H. Kao, Susan Manzi & Joseph M. Ahearn. (2013) Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Therapeutic Advances in Musculoskeletal Disease 5:4, pages 210-233.
Crossref
Piotr Piotrowski, Margarita Lianeri, Mariusz Wudarski, Marzena Olesińska & Paweł P. Jagodziński. (2012) Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus. Rheumatology International 33:5, pages 1121-1125.
Crossref
Mariele Gatto, Margherita Zen, Anna Ghirardello, Silvano Bettio, Nicola Bassi, Luca Iaccarino, Leonardo Punzi & Andrea Doria. (2013) Emerging and critical issues in the pathogenesis of lupus. Autoimmunity Reviews 12:4, pages 523-536.
Crossref
S. Sam Lim & Cristina Drenkard. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 8 24 .
A. Doria, M. Zen, S. Bettio, M. Gatto, N. Bassi, L. Nalotto, A. Ghirardello, L. Iaccarino & L. Punzi. (2012) Autoinflammation and autoimmunity: Bridging the divide. Autoimmunity Reviews 12:1, pages 22-30.
Crossref
Andrea Doria, Jean-Michel Dayer & Leonardo Punzi. (2012) Autoinflammatory diseases: How to put the fire inside the body out?. Autoimmunity Reviews 12:1, pages 1-4.
Crossref
Raghav Gupta, Thomas A. Hennebry & Gary T. Kinasewitz. (2012) Pleuropericardial effusion after 37 years of sulfasalazine therapy. Journal of Cardiovascular Medicine 13:8, pages 541-543.
Crossref
Judith A. James & Julie M. Robertson. (2012) Lupus and Epstein-Barr. Current Opinion in Rheumatology 24:4, pages 383-388.
Crossref
Kelly A. Jones, Besa Smith, Nisara S. Granado, Edward J. Boyko, Gary D. Gackstetter, Margaret A.K. Ryan, Christopher J. Phillips & Tyler C. Smith. (2012) Newly Reported Lupus and Rheumatoid Arthritis in Relation to Deployment Within Proximity to a Documented Open-Air Burn Pit in Iraq. Journal of Occupational & Environmental Medicine 54:6, pages 698-707.
Crossref
XINJUN LI, JAN SUNDQUIST, KRISTINA SUNDQUIST & BENGT ZÖLLER. (2012) Occupational Risk Factors for Systemic Lupus Erythematosus: A Nationwide Study Based on Hospitalizations in Sweden. The Journal of Rheumatology 39:4, pages 743-751.
Crossref
N Bassi, R Luisetto, D Del Prete, A Ghirardello, M Ceol, S Rizzo, L Iaccarino, M Gatto, ML Valente, L Punzi & A Doria. (2012) Induction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA). Lupus 21:2, pages 203-209.
Crossref
Piotr Piotrowski, Margarita Lianeri, Marzena Olesińska & Paweł P. Jagodziński. (2011) Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus. Molecular Biology Reports 39:2, pages 1343-1347.
Crossref
Anette Holck Draborg, Karen Duus & Gunnar Houen. (2012) Epstein-Barr Virus and Systemic Lupus Erythematosus. Clinical and Developmental Immunology 2012, pages 1-10.
Crossref
Susan Yung & Tak Mao Chan. (2012) The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis. Autoimmune Diseases 2012, pages 1-9.
Crossref
Teresa WarchołAdriana MostowskaMargarita LianeriJan K. ŁąckiPaweł P. Jagodziński. (2012) XRCC1 Arg399Gln Gene Polymorphism and the Risk of Systemic Lupus Erythematosus in the Polish Population . DNA and Cell Biology 31:1, pages 50-56.
Crossref
PEI-CHUN CHANG, YI CHEN, MING-TSONG LAI, HENG-YUAN CHANG, CHUNG-MING HUANG, HSIN-PING LIU, WEI-YONG LIN, CHIH-HO LAI, JIM JINN-CHYUAN SHEU & FUU-JEN TSAI. (2011) Association Analysis of Polymorphisms in Lumican Gene and Systemic Lupus Erythematosus in a Taiwan Chinese Han Population. The Journal of Rheumatology 38:11, pages 2376-2381.
Crossref
Keith B. ElkonVivian V. Stone. (2011) Type I Interferon and Systemic Lupus Erythematosus. Journal of Interferon & Cytokine Research 31:11, pages 803-812.
Crossref
Susan P. Phillips. (2011) Including Gender in Public Health Research. Public Health Reports 126:3_suppl, pages 16-21.
Crossref
Matlock A Jeffries & Amr H Sawalha. (2011) Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. International Journal of Clinical Rheumatology 6:4, pages 423-438.
Crossref
Angelika Antoni, Vimal A. Patel, Hanli Fan, Daniel J. Lee, Lee H. Graham, Cristen L. Rosch, Daniel S. Spiegel, Joyce Rauch & Jerrold S. Levine. (2011) Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes. Immunogenetics 63:5, pages 291-308.
Crossref
Lars Rönnblom, Gunnar V. Alm & Maija-Leena Eloranta. (2011) The type I interferon system in the development of lupus. Seminars in Immunology 23:2, pages 113-121.
Crossref
Sharon A. Chung, Kimberly E. Taylor, Robert R. Graham, Joanne Nititham, Annette T. Lee, Ward A. Ortmann, Chaim O. Jacob, Marta E. Alarcón-Riquelme, Betty P. Tsao, John B. Harley, Patrick M. Gaffney, Kathy L. Moser, Michelle Petri, F. Yesim Demirci, M. Ilyas Kamboh, Susan Manzi, Peter K. Gregersen, Carl D. Langefeld, Timothy W. Behrens & Lindsey A. Criswell. (2011) Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production. PLoS Genetics 7:3, pages e1001323.
Crossref
Satyanarayana Swamy Cheekatla & Vikas Agarwal. (2011) Autoimmunity. Indian Journal of Rheumatology 6:1, pages 26-27.
Crossref
Kelly A. Jones, Nisara S. Granado, Besa Smith, Donald J. Slymen, Margaret A. K. Ryan, Edward J. Boyko, Gary D. Gackstetter, Christopher J. Phillips & Tyler C. Smith. (2011) A Prospective Study of Lupus and Rheumatoid Arthritis in Relation to Deployment in Support of Iraq and Afghanistan: The Millennium Cohort Study. Autoimmune Diseases 2011, pages 1-13.
Crossref
Yuko Minami, Yasuhiko Hirabayashi, Chisato Nagata, Tomonori Ishii, Hideo Harigae & Takeshi Sasaki. (2011) Intakes of Vitamin B6 and Dietary Fiber and Clinical Course of Systemic Lupus Erythematosus: A Prospective Study of Japanese Female Patients. Journal of Epidemiology 21:4, pages 246-254.
Crossref
Magdalena Olszanecka-Glinianowicz, Antoni Hrycek & Paweł Cieélik. 2011. Neuroinflammation. Neuroinflammation 467 485 .
B. Yu, Y. Shao, P. Li, J. Zhang, Q. Zhong, H. Yang, X. Hu, B. Chen, X. Peng, Q. Wu, Y. Chen, M. Guan, J. Wan & W. Zhang. (2010) Copy number variations of the human histamine H4 receptor gene are associated with systemic lupus erythematosus. British Journal of Dermatology 163:5, pages 935-940.
Crossref
A. LesiakJ. Narbutt, A. Sysa-Jedrzejowska, J. Lukamowicz, DP McCauliffe & A. Wózniacka. (2010) Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus. Lupus 19:6, pages 683-688.
Crossref
Virgilio Gómez-Rubio & Antonio López-Quílez. 2010. Rare Diseases Epidemiology. Rare Diseases Epidemiology 151 171 .
Paolo Sfriso, Anna Ghirardello, Costantino Botsios, Michele Tonon, Margherita Zen, Nicola Bassi, Franco Bassetto & Andrea Doria. (2010) Infections and autoimmunity: the multifaceted relationship. Journal of Leukocyte Biology 87:3, pages 385-395.
Crossref
K Kim, Y-K Sung, C P Kang, C-B Choi, C Kang & S-C Bae. (2009) A regulatory SNP at position −899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis. Genes & Immunity 10:5, pages 482-486.
Crossref
Xinjun Li, Jan Sundquist & Kristina Sundquist. (2009) Risks of rheumatic diseases in first- and second-generation immigrants in Sweden: A nationwide followup study. Arthritis & Rheumatism 60:6, pages 1588-1596.
Crossref
K Anam, M Amare, S Naik, KA Szabo & TA Davis. (2009) Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus 18:4, pages 318-331.
Crossref
Kristina L Demas & Karen H Costenbader. (2009) Disparities in lupus care and outcomes. Current Opinion in Rheumatology 21:2, pages 102-109.
Crossref
Edith M. Williams, Luis E. Zayas, Judith Anderson, Adrianne Ransom & Laurene Tumiel-Berhalter. (2009) Reflections on Lupus and the Environment in an Urban African American Community. Humanity & Society 33:1-2, pages 5-17.
Crossref
A Doria, M Canova, M Tonon, M Zen, E Rampudda, N Bassi, F Atzeni, S Zampieri & A Ghirardello. (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmunity Reviews 8:1, pages 24-28.
Crossref
A H Sawalha, M Jeffries, R Webb, Q Lu, G Gorelik, D Ray, J Osban, N Knowlton, K Johnson & B Richardson. (2008) Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes & Immunity 9:4, pages 368-378.
Crossref
J A Kelly, J M Kelley, K M Kaufman, J Kilpatrick, G R Bruner, J T Merrill, J A James, S G Frank, E Reams, E E Brown, A W Gibson, M C Marion, C D Langefeld, Q-Z Li, D R Karp, E K Wakeland, M Petri, R Ramsey-Goldman, J D Reveille, L M Vilá, G S Alarcón, R P Kimberly, J B Harley & J C Edberg. (2008) Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes & Immunity 9:3, pages 187-194.
Crossref
A DoriaC Briani. (2008) Lupus: improving long-term prognosis. Lupus 17:3, pages 166-170.
Crossref
Lucio Lo Russo, Stefano Fedele, Rosario Guiglia, Domenico Ciavarella, Lorenzo Lo Muzio, Pio Gallo, Chiara Di Liberto & Giuseppina Campisi. (2008) Diagnostic Pathways and Clinical Significance of Desquamative Gingivitis. Journal of Periodontology 79:1, pages 4-24.
Crossref
Andrea Doria, Silvia Arienti, Mariaelisa Rampudda, Mariagrazia Canova, Michele Tonon & Piercalo Sarzi-Puttini. (2008) Preventive strategies in systemic lupus erythematosus. Autoimmunity Reviews 7:3, pages 192-197.
Crossref
Amr H. Sawalha & Matlock Jeffries. (2007) Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. European Journal of Immunology 37:5, pages 1407-1413.
Crossref
A Wozniacka, A Lesiak, J Narbutt, J Kobos, S Pavel & A Sysa-Jedrzejowska. (2016) Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus. Lupus 16:2, pages 89-94.
Crossref
A. Jansson, U. Wintergerst, S. Bechtold & B. H. Belohradsky. (2006) Rituximab bei therapieresistentem systemischem Lupus erythematodesRituximab for therapy-refractory systemic lupus erythematosus. Monatsschrift Kinderheilkunde 154:10, pages 990-995.
Crossref
Judith A James, John B Harley & R Hal Scofield. (2006) Epstein–Barr virus and systemic lupus erythematosus. Current Opinion in Rheumatology 18:5, pages 462-467.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.